Experience with ustekinumab for the treatment of moderate to severe Hidradenitis suppurativa

Abstract

Ustekinumab may provide a safe and effective new treatment strategy for HS in some patients. Interleukin 12/23 inhibition is a potential therapeutic option for patients in which other therapies prove ineffective.